Proteomic Analysis Implicates Translationally Controlled Tumor Protein as a Novel Mediator of Occlusive Vascular Remodeling in Pulmonary Arterial Hypertension
Authors:
- Jessie R. LavoieJLJessie R. Lavoie
- Mark L. OrmistonMOMark L. Ormiston
- Carol Perez-IratxetaCPCarol Perez-Iratxeta
- David W. CourtmanDCDavid W. Courtman
- Baohua JiangBJBaohua Jiang
- Elisabet FerrerEFElisabet Ferrer
- Paola CarusoPCPaola Caruso
- Mark SouthwoodMSMark Southwood
- William S. FosterWFWilliam S. Foster
- Nicholas W. MorrellNMNicholas W. Morrell
- Duncan J. StewartDSDuncan J. Stewart
- 27 May 2014
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 129 (21) , 2125-2135
Abstract
Background—: Pulmonary arterial hypertension (PAH) is a lethal disease characterized by excessive proliferation of pulmonary vascular endothelial cells (ECs). Hereditary PAH (HPAH) is often caused by mutations in the bone morphogenetic protein receptor type 2 gene ( BMPR2 ). However, the mechanisms by which these mutations cause PAH remain unclear. Therefore, we screened for dysregulated proteins in blood-outgrowth ECs of HPAH patients with BMPR2 mutations compared with healthy control subjects. Methods and Results—: A total of 416 proteins were detected with 2-dimensional PAGE in combination with liquid chromatography/tandem mass spectrometry analysis, of which 22 exhibited significantly altered abundance in blood-outgrowth ECs from patients with HPAH. One of these proteins, translationally controlled tumor protein (TCTP), was selected for further study because of its well-established role in promoting tumor cell growth and survival. Immunostaining showed marked upregulation of TCTP in lungs from patients with HPAH and idiopathic PAH, associated with remodeled vessels of complex lesions. Increased TCTP expression was also evident in the SU5416 rat model of severe and irreversible PAH, associated with intimal lesions, colocalizing with proliferating ECs and the adventitia of remodeled vessels but not in the vascular media. Furthermore, silencing of TCTP expression increased apoptosis and abrogated the hyperproliferative phenotype of blood-outgrowth ECs from patients with HPAH, raising the possibility that TCTP may be a link in the emergence of apoptosis-resistant, hyperproliferative vascular cells after EC apoptosis. Conclusion—: Proteomic screening identified TCTP as a novel mediator of endothelial prosurvival and growth signaling in PAH, possibly contributing to occlusive pulmonary vascular remodeling triggered by EC apoptosis.Keywords
This publication has 49 references indexed in Scilit:
- Histamine-releasing factor has a proinflammatory role in mouse models of asthma and allergyJournal of Clinical Investigation, 2012
- Upregulation of TCTP expression in human skin squamous cell carcinoma increases tumor cell viability through anti-apoptotic action of the proteinExperimental and Therapeutic Medicine, 2011
- Altered MicroRNA Processing in Heritable Pulmonary Arterial Hypertension: An Important Role for Smad-8American Journal of Respiratory and Critical Care Medicine, 2011
- Proteomic Analysis of Lung Tissues From Patients With Pulmonary Arterial HypertensionCirculation, 2010
- Caspase-3-dependent export of TCTP: a novel pathway for antiapoptotic intercellular communicationCell Death & Differentiation, 2010
- Molecular analysis of endothelial progenitor cell (EPC) subtypes reveals two distinct cell populations with different identitiesBMC Medical Genomics, 2010
- Role of apoptosis in pulmonary hypertension: From experimental models to clinical trialsPharmacology & Therapeutics, 2010
- Pathology of Pulmonary HypertensionClinics in Chest Medicine, 2007
- Intracellular Targeting of the Type-Iα Regulatory Subunit of cAMP-Dependent Protein KinaseTrends in Cardiovascular Medicine, 2002
- Origins of circulating endothelial cells and endothelial outgrowth from bloodJournal of Clinical Investigation, 2000